Stockreport

OPKO Health (OPK) And Entera Bio Announce Data for GLP-2 [Yahoo! Finance]

Opko Health, Inc.  (OPK) 
Last opko health, inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NYSE Investor Relations: investor.opko.com
PDF exclusive N-Tab technology with a long-acting, proprietary GLP-2 agonist created by OPK. The program's primary objective is to create the first and only GLP-2 peptide [Read more]